Mechanistically, MTA2 deficiency in mice leads to increased H3K27 acetylation at both Igll1 and VpreB1 promoters. Gene profiling analyses also identify distinct MTA2-dependent transcription programs in pro-B and pre-B cells. In addition, we find a strong synergy between MTA2 and OCA-B in repressing Igll1 and VpreB1 at the pre-B cell stage, and in regulating both the pre-B to immature B transition and splenic B cell development.
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In Brief Lu et al. examine B cell developmental defects in MTA2-deficient mice. MTA2 interacts with AIOLOS/IKAROS, represses Igll1 expression, co-binds to most AIOLOS/IKAROS target genes in pre-B cells, and cooperates with OCA-B in the pre-B to immature B transition. These data suggest that AIOLOS/IKAROS functions through MTA2/NuRD during B cell development.
INTRODUCTION
Mammalian B lymphocyte development is a tightly regulated multi-step process that proceeds from hematopoietic stem cells (HSCs) in the bone marrow through several intermediate progenitor cell stages, including multipotent progenitors (MPPs), earliest lymphocyte progenitors (ELPs), and common lymphoid progenitors (CLPs), before differentiation into B cells. Intensive studies over the past decades have implicated multiple key transcription factors (TFs) in the regulation of B cell development, including factors (e.g., PU.1, Ikaros, BCL11a, E2A, EBF, and -PAX5) that act either positively to promote B cell-specific gene expression or negatively to repress non-B lineage programs (Busslinger, 2004; Matthias and Rolink, 2005) . These sequence-specific TFs achieve activation or repression of target genes through interactions both with the general transcription machinery and with chromatin regulators (e.g., histone modification enzymes and chromatin remodeling complexes), but how specific chromatin regulators contribute to B cell development remains largely unknown (Busslinger and Tarakhovsky, 2014) .
Among chromatin-modifying factors, the heterogeneous NuRD (nucleosome remodeling histone deacetylase) complex is of special interest because it possesses both ATP-dependent nucleosome remodeling and histone deacetylase activities. The mammalian NuRD complexes are composed of both common factors (HDAC1/2, RbAp46/48) and variable modular factors that result in related heterogeneous complexes that likely modulate different transcriptional programs (Dege and Hagman, 2014; Feng and Zhang, 2003) . Thus, beyond the common components, NuRD complexes variably contain a member (either CHD3/MI-2a or CHD4/MI-2b) of the CHD family of ATP-dependent chromatin remodeling factors, a member (MTA1, MTA2, or MTA3) of the metastasis-associated factor MTA family, a member (MBD2 or MBD3) of the methyl-CpG binding domain proteins, and either P66a or P66b (whose functions are likely to be mediated through interactions with core histones and MBD2) (Dege and Hagman, 2014; Denslow and Wade, 2007) . In vivo and cell-based studies have demonstrated important and non-redundant functions of different NuRD modular components in multiple biological processes that include embryonic stem cell (ESC) maintenance, tumor progression, circadian clock regulation, synaptic differentiation, and granule neuron function in the cerebellum cortex (Dege and Hagman, 2014; Denslow and Wade, 2007; Kim et al., 2014; Sen et al., 2014; Yamada et al., 2014; Yang et al., 2016) .
In relation to NuRD function in lymphogenesis, of primary interest here, previous studies have demonstrated (1) an association of MI-2b/NuRD with IKAROS and AIOLOS in T cells (Avitahl et al., 1999; Zhang et al., 2011) ; (2) reductions in CD4 + T cell number and Cd4 gene expression (Williams et al., 2004) ; (3) abnormal HSC homeostasis and defective differentiation into myeloid and lymphoid lineages (Yoshida et al., 2008) , following Mi-2b inactivation; (4) an MI-2b requirement for maintaining DNA-hypermethylated chromatin at the mb1 gene promoter (Gao et al., 2009 ); (5) spontaneous B cell lymphomagenesis following Mta1 overexpression in vivo (Bagheri-Yarmand et al., 2007) ; (6) an important role for Mta3 in plasma cell differentiation (Fujita et al., 2004) ; and (7) MBD3/NuRD-mediated repression of the B cell transcription program in multipotent lymphoid progenitors in order to maintain a balanced differentiation of T and B lineage cells (Loughran et al., 2017) . Related, our previous data showed that Mta2-deficient mice develop lupus-like autoimmune symptoms (Lu et al., 2008) . However, the role of distinct NuRD complexes in normal B cell development and the transcriptional programs they regulate remain to be elucidated.
Here, we have characterized a number of conventional, conditional mutant and double-mutant mouse models in order to delineate specific phenotypes in B cell development, allowing us to link the MTA2 component of the MTA2/NuRD complex to the lymphocyte-specific transcription factor AIOLOS and the B cell-specific transcription coactivator OCA-B (Luo and Roeder, 1999; Teitell, 2003) in vivo. We also identified distinct groups of genes regulated by MTA2 in pro-B and pre-B cells.
RESULTS

B Cell Developmental Defects in Mta2 Conventional and Conditional Knockout (KO) Mice
To understand the function of MTA2/ NuRD in B cell development, we first analyzed the bone marrow (BM) B cell subpopulations in 1.5-to 2.5-month-old Mta2 conventional null (D/D) (n = 5) and littermate control mice that include both wild type and Mta2 heterozygous mice (n = 11). The Mta2 null strain was derived by crossing EIIa-Cre transgenic mice with Mta2 fl/fl mice (Lu et al., 2008) . Mta2 null mice showed decreased frequencies of immature B (B220 
Vav-Cre Mta2
fl/fl and control mice; t test; **p < 0.01, ***p < 0.001).
(C) qPCR results indicating efficiencies of Vav-Cre-mediated deletion of Mta2 allele in indicated cell populations (n = 4 for each cell subsets; t test; ***p < 0.001).
(legend continued on next page) more importantly, to assess the B cell-autonomous defects, we generated (Krop et al., 1996) . Mb1 encodes the Iga subunit of the pre-BCR (B cell receptor) complex and is expressed earlier in development than Cd19 (Hobeika et al., 2006) . Surprisingly, fluorescence-activated cell sorting (FACS) analysis showed largely normal pro-B and pre-B cell compartments in Cd19-Cre Mta2 Figure 2C ). Within the pro-B cell population, there is more than 50 percent reduction in both Hardy Fractions B (Fr. B) and C (Fr. C) cells when MTA2 is lost ( Figure 2D ). qPCR analyses show that Mta2 inactivation results in abnormal rearrangement of immunoglobulin (Ig) heavy chain genes (such as V H J558-J H3 and V H J7183-J H3 ) in pro-B cells (Figure 2E) . Regarding the pre-B cell population, Vav-Cre Mta2 fl/fl mice contain a higher percentage of large pre-B cells and fewer small pre-B cells than control mice ( Figure 2F ), suggesting a cell cycle defect in these mutant pre-B cells (which might explain the decreased number of immature B cells in mutant mice). In addition, we also find abnormal Ig k chain rearrangements in Vav-Cre Mta2 fl/fl small pre-B cells ( Figure 2G ). Furthermore, the distal recombination events seem to be more affected by Mta2 inactivation than are the proximal recombination events, suggesting a premature termination of the recombination process ( Figure 2G ).
MTA2/NuRD-AIOLOS/IKAROS Interaction and MTA2-Dependent Repression of Pre-BCR Genes
Altogether, the B cell phenotypes described above, as well as other defects of the immune system caused by Mta2 inactivation (Lu et al., 2008) , were reminiscent of those found in mice lacking AIOLOS, a member of the IKAROS family and a key regulator of lymphocyte function (Wang et al., 1998) . IKAROS and AIOLOS were found to be stably associated with NuRD complexes in T cells (Kim et al., 1999; Zhang et al., 2011) . To assess whether MTA2/NuRD interacts with AIOLOS in B cells, nuclear extracts (NEs) from human pre-B leukemia 697 cells were subjected to immunoprecipitation with antibodies to MTA2, MI-2b, AIOLOS, and IKAROS ( Figure 3A) . The results show reciprocal co-immunoprecipitation between AIOLOS, IKAROS, and NuRD components MTA2 and MI-2b ( Figure 3A ), and were confirmed with NE from Namalwa cells (of germinal center origin) ( Figure S3A ). Thus, both phenotypic similarities and direct biochemical evidence suggested that Mta2-deficient mice may have other B cell developmental defects similar to those observed in Aiolos KO mice. During mouse BM B cell development, immunoglobulin heavy chain (IgM) rearrangement occurs at the pro-B stage. The heavy chain then associates with the surrogate light chain (SLC), composed of LAMBDA5 (l5) and VPREB proteins. Aiolos expression is upregulated at the pro-B to pre-B cell transition stage, and Igll1 (encoding l5) and VpreB1 genes are downregulated at the pre-B stage. In Aiolos-null pre-B cells, both Igll1 and Vpreb1 are derepressed-demonstrating a key role of Aiolos in silencing these genes at this stage (Karnowski et al., 2008; Thompson et al., 2007) . In addition, Ikaros overexpression in mouse pre-B cells also results in decreased Igll1 expression (Ferreiró s-Vidal et al., 2013) . To test whether MTA2 is also involved in pre-BCR gene silencing, we examined Igll1 and VpreB1 expression levels in small pre-B cells (B220 Figures  S3C and S3D ). To examine whether MTA2/NuRD regulates pre-BCR genes directly, chromatin immunoprecipitation (ChIP) assays were performed using 697 human pre-B leukemia cells. The data demonstrate significant enrichments of MTA2, MI-2b, AIOLOS, and IKAROS at IGLL1 and VPREB1 promoters (Figure 3C) . Thus, both genetic and biochemical experiments clearly demonstrate that MTA2/NuRD directly interacts with AIOLOS and (G) qPCR results indicating relative abundances of different VJ rearrangements in small pre-B cells isolated from mice with indicated genotypes (n = 4 for each genotype; t test; *p < 0.05, **p < 0.01, ***p < 0.001).
IKAROS in developing B cells, and jointly targets pre-BCR gene loci. ChIP assays demonstrated that loss of MTA2 activity leads to increase of histone H3 lysine 27 acetylation (H3K27Ac) at both Igll1 and VpreB1 promoters ( Figure 3D ), indicating the mechanism underlying the increased Igll1 and Vpreb1 expression in Mta2-deficient pre-B cells.
Highly Overlapping Genomic Distributions of MTA2, HDAC2, AIOLOS, and IKAROS in Human Pre-B Cells To better understand the MTA2/NuRD-dependent gene regulation and its relationship to AIOLOS and IKAROS, we examined the genomic distributions of MTA2, HDAC2 (another subunit of NuRD complex), AIOLOS, and IKAROS in 697 cells by chromatin immunoprecipitation sequencing (ChIP-seq). These analyses identified about 28,760 MTA2 peaks, with 19% at promoter regions, 44% at intragenic regions (including introns, exons, 5 0 and 3 0 UTR regions), and 34% at intergenic regions (including distal enhancers) ( Figure 4A ). HDAC2, AIOLOS, and IKAROS showed similar distribution patterns ( Figure 4A) . A further examination of the average distance from the binding sites of these factors to transcription start sites (TSSs) and enhancers revealed enrichment of all these factors slightly upstream of the TSS ( Figure 4B ). At enhancer regions, all four factors showed almost the same binding patterns ( Figure 4B ). Furthermore, the ChIP-seq data showed a striking overlap between target genes bound by these factors ( Figure 4C ). For example, about 90% of the MTA2 target genes are also AIOLOS targets, more than 90% of the HDAC2 targets are also MTA2 targets, and more than 90% of AIOLOS targets are also IKAROS targets ( Figure 4C ). A heatmap generated by normalized read densities from individual ChIP-seq data centered at TSSs and ranked by AIOLOS peak signals further demonstrates the high degree of AIOLOS/IKAROS and MTA2/ HDAC2 colocalization at promoter regions ( Figure 4D ). These data strongly support a model in which AIOLOS/IKAROS recruits the MTA2/ NuRD complex to repress target genes in pre-B cells.
Toward the identification of DNA sequence elements recognized by MTA2, HDAC2, AIOLOS, and IKAROS, respectively, motif analyses indicated that the top binding sites preferred by MTA2, HDAC2, and AIOLOS/IKAROS include motifs recognized by EBF1, RUNX1, and ETS family members (FLI1, ERG, and ETV2) ( Figure 4E ). The more detailed summaries of DNA motifs recognized by these factors are listed in Tables S1-S4 . These data suggest a model in which AIOLOS/IKAROS/NuRD function, at least partially, by repressing target genes of EBF1, RUNX1, and ETS family transcription factors in pre-B cells. This notion is consistent with a previously proposed model that AIOLOS represses Igll1 expression at the pre-B stage by competing with EBF1 at the same DNA binding site (Thompson et al., 2007) .
The ChIP-seq data also confirm that the IGLL1 and VPREB1 promoters are loaded with AIOLOS and NuRD components MTA2 and HDAC2 ( Figure 4F ), and that this is also the case for (legend continued on next page) the promoters of the CD79A and CD79B genes (encoding the Iga and Igb subunits of the pre-BCR/BCR complexes) ( Figure 4F ). For a group of genes, such as CD86 and BCL2, AIOLOS/IKAROS and NuRD do not bind to the promoter regions but instead bind to the intronic and 3 0 UTR elements ( Figures S4A and S4B ). Interestingly, the expression levels of Cd86 and Bcl2 are elevated in Mta2-deficient murine pre-B cells (data not shown), suggesting a possible enhancer-mediated transcription repression for these genes.
MTA2-Dependent Transcriptional Program in Pro-B and Pre-B Cells
To understand the molecular basis of pro-B and pre-B defects observed in Vav-Cre Mta2 fl/fl mice and to assess MTA2/NuRDregulated transcriptional programs in these cells, we performed RNA-sequencing (RNA-seq) analyses using pro-B cells and small pre-B cells from Vav-Cre Mta2 fl/fl and control mice (the cell sorting strategies are like the ones shown in Figure S3B ) ( Figure 5A ). Consistent with the observation that MTA2 enhances HDAC activity in vitro, as well as a general role of HDACs in gene repression (Feng and Zhang, 2003) , many more genes were upregulated (440 genes >1.5-fold) than downregulated (88 genes >1.5-fold) in pro-B cells upon Mta2 inactivation ( Figure 5B ). Among upregulated genes, about 8% (37) showed more than 3-fold increases in expression, while the rest (403) showed 1.5-to 3-fold increases in expression ( Figure 5B ). Among downregulated genes, about 6% (5) showed more than 3-fold reductions in expression, whereas 94% (83) showed 1.5-to 3-fold reductions ( Figure 5B ). A gene ontology (GO) analysis of upregulated genes in Mta2-deficient pro-B cells showed that the top enriched pathways or cellular processes include neutrophil degranulation and activation (e.g., Cd14, Cd63, Chit1, Ckap4, Lrg1, etc.) ; inflammatory responses (e.g., Cebpb, Csf1r, Ptgir, Cd6, Cxcr2, etc.) ; cell junction and extracellular matrix (ECM) relationships (e.g., Tjp1, Prtn3, Itgb4, Col5a1, etc.); macromolecule metabolism (e.g., Acvrl1, ccr1, and Cd3e, etc.); and endocytosis (e.g., Cd63 Lrp1, Hip1, Apoe, etc.) ( Figure 5C ). Other genes that showed more substantial (>3-fold) upregulation in Mta2-deficient pro-B cells include the following: Gpr4, Asprv1, Rcn3, Ly6a, Padi3, etc. In the small pre-B cell compartment, there also were more genes upregulated (435 genes) than downregulated (229 genes) upon Mta2 inactivation (>1.5-fold) ( Figure 5B ). Among upregulated genes, about 15% (62) showed more than 3-fold increases in expression, while the rest (373) showed 1.5-to 3-fold increases in expression ( Figure 5B ). Among downregulated genes, only 5% (12) showed more than 3-fold reductions in expression, whereas 95% showed 1.5-to 3-fold reductions ( Figure 5B) . A GO analysis showed that the top enriched pathways/cellular processes in Mta2-deficient pre-B cells include the following: T cell receptor (TCR) and T cell differentiation (e.g., Lck, Thy1, Lat, Zap70, etc.), regulation of apoptosis (e.g., Bcl2, Ccnd2, Socs2, etc.) , and inositol phosphate metabolism (e.g., Plcd3, Plcb3, Inpp4a, etc.) ( Figure 5C ). Intriguingly, a group of genes involved in axon guidance (e.g., Plxnd1, Plxnb2, Plxnc1, etc.) are also repressed by MTA2 in pre-B cells ( Figure 5C ). A comparison of our RNA-seq data with previously reported gene profiling data revealed that genes normally silenced during BM B cell differentiation from Hardy Fr C 0 (cycling pre-B) to Fr D (resting pre-B) stages (Ferreiró s-Vidal et al., 2013) are enriched in upregulated genes in Vav-Cre Mta2 fl/fl small pre-B cells (Figure S5A) , indicating an important role of MTA2/NuRD at this development stage. Other MTA2-regulated genes that showed substantial upregulation (>3.5-fold) include the following: Crhbp, Atp11a, Trim63, Ikzf2 (Helios), Gprasp2, Rcn3, H1f0, etc. Our RNA-seq data also confirmed increased expression of Igll1 and VpreB1 genes in small pre-B cells. Among MTA2-repressed genes in small pre-B cells, about 70% have MTA2 binding sites at loci of their human orthologs in 697 cells ( Figure S5B ), suggesting that these are potential direct MTA2 target genes in mouse pre-B cells. It is noteworthy that only 96 genes (21% of upregulated genes in Mta2-deficient pro-B cells, 22% of upregulated genes in Mta2-deficient small pre-B cells) are repressed by MTA2 in both pro-B cells and in pre-B cells (Figures 5C and S5C) , suggesting that MTA2/NuRD regulates distinct transcriptional programs at different B cell developmental stages. The expression levels of a selected group of genes identified in Mta2-deficient pre-B cells by RNA-seq analyses have also been validated by RT-qPCR assays using cohorts of mice different from those used for RNA-seq analyses ( Figure S5D ).
Derepression of Pre-BCR Genes and a Pre-B to
Immature B Transition Defect in Mice Lacking Both Mta2 and Oca-B Genes In addition to the fact that AIOLOS is a key transcription factor in repression of lgll1 and VpreB1 genes at the pre-B cell stage (Thompson et al., 2007) , we previously found that the B cell-selective transcription coactivator OCA-B also represses Igll1 and VpreB1 genes at the pre-B stage through an interaction with SYK kinase in the cytoplasm (Siegel et al., 2006) . Interestingly, the joint loss of AIOLOS and OCA-B caused a greater derepression of lgll1 and VpreB1 genes in pre-B cells than was observed in either of the single-KO mice, and also caused a more severe defect in the pre-B to immature B cell transition (Karnowski et al., 2008 , and n = 7 for DKO mice; t test; *p < 0.05, ***p < 0.001).
(legend continued on next page)
showed an increased large pre-B to small pre-B cell ratio and abnormal Ig light chain k rearrangements ( Figures 6C and 6D) .
We mice showed a decrease in the MZB cell population ( Figures  7D and 7E ), the DKO mice exhibited dramatic decreases in both FOB and MZB populations-thus demonstrating an MTA2 and/or OCA-B requirement for the development of splenic B cell compartments ( Figures 7D and 7E ). These data further support our hypothesis that AIOLOS functions in peripheral B cells through its interaction with MTA2/NuRD. Figure 5C ). In pre-B cells, the major pathways repressed by MTA2/NuRD include TCR signaling and T cell differentiation, regulation of apoptosis, and axon guidance ( Figure 5C ). It thus appears that MTA2/NuRD is involved in the repression of non-B lineage genes at both pro-B and pre-B stages. Furthermore, a gene set enrichment analysis (GSEA) indicates that genes normally silenced during Hardy Fr C 0 (cycling pre-B) to Hardy Fr D (resting pre-B) differentiation are enriched in upregulated genes in Mta2-deficient small pre-B cells. It is worth noting that, although other MTA family member genes, namely Mta3 and Mta1, are also expressed in different B subsets cells, our data demonstrate non-redundant functions of MTA2 during B cell development. Further analyses are required to elucidate the unique function of MTA1 and MTA3 and redundant function between MTA family members during B cell development. The B cell phenotypes described above and other defects of immune system caused by loss of MTA2 function are strikingly similar to those associated with loss of AIOLOS function (Table S5 ; Karnowski et al., 2008; Lu et al., 2008; Sun et al., 2003; Wang et al., 1998) . Consistent with previous observations of an IKAROS/AIOLOS/NuRD association in T cells (Kim et al., 1999; Zhang et al., 2011) , we have shown a physical interaction between AIOLOS/IKAROS and MTA2/NuRD in B cells. This observation opened a window into the functional interplay between AIO-LOS/IKAROS and MTA2/NuRD complexes. Specifically, it was already noted that Igll1 and VpreB1, two genes central to the pre-B cell differentiation, are derepressed in Aiolos À/À pre-B cells OCA-B is a transcription coactivator that plays an essential role in GC formation and transcription of secondary Ig genes, and that is also involved in B cell development in the bone marrow (Luo and Roeder, 1999; Siegel et al., 2006) . Our previous study had shown that OCA-B represses pre-BCR genes Igll1 and VpreB1 in pre-B cells, likely through its interaction with SYK kinase in the cytoplasm (Siegel et al., 2006) . However, the current ChIP data demonstrate a direct binding of OCA-B and its interacting transcription factor OCT2 at IGLL1 and VPREB1 promoters in 697 cells. Moreover, 
OCA-B knockdown in 697 cells reproduces the derepression of
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Robert G. Roeder (roeder@rockefeller.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
Mice were maintained in environmental control facilities at the Rockefeller University and the University of North Carolina at Chapel Hill. Mice of both sexes were 8 to 12 weeks old unless otherwise indicated. The mouse maintenance and experiments were performed following the Institutional Animal Care and Use Committee (IACUC) approved protocols of the Rockefeller University and University of North Carolina at Chapel Hill. Mice carrying Mta2 conditional alleles (Mta2 fl/fl ) were generated as described before (Lu et al., 2008) . The Cd19-Cre mice, Mb1-Cre mice, Mx1-Cre transgenic mice, Vav1-Cre mice and Oca-B knockout (KO) mice were described previously (Hobeika et al., 2006; Kim et al., 1996; K€ uhn et al., 1995; Ogilvy et al., 1999; Rickert et al., 1997) . The Mta2 KO mice (D/D) were derived by crossing EIIa-Cre transgenic mice with Mta2 fl/fl mice (Lu et al., 2008) . Mta2 D/D and littermate or age-matched control mice were of mixed B6/129 genetic background. The conditional KO mice had been backcrossed with C57/BL6 mice for at least six generations. For induction of Mx1-Cre transgene expression, Mx1-Cre Mta2 flfl and littermate Mta2 flfl mice received two intraperitoneal injections of poly (I:C) (250 mg) at day 28 and day 30 of age. Mouse genomic DNA was isolated using DNeasy Blood and Tissue Kit (QIAGEN) for genotyping. The primers for genotyping Mta2 alleles and Oca-B alleles can be found in Table S6 . The primers for genotyping other transgenic mouse strains described above can be found at the corresponding websites of The Jackson Laboratory (https://www.jax.org/).
Cell Line 697 cells are human pre-B leukemia cells that carry the E2A-PBX1 fusion gene (Kamps et al., 1991) and were cultured with RPMI 1640, 10% fetal bovine serum (FBS). Namalwa cells are human Burkitt's lymphoma cells and were cultured with RPMI 1640, 10% FBS.
METHOD DETAILS Flow Cytometry
Mta2 mutant and Oca-B mutant mice, and littermate control or age-, sex-matched control mice were used for analysis. Single cell suspensions of bone marrow cells and spleen cells were stained with FITC-, PE-, PerCP/Cy5.5-, PE/Cy7-, Brilliant Violet 605-, and APC-conjugated monoclonal antibodies (described in Key Resources Table) and DAPI. Stained cells were analyzed with either BD LSR II or BD FACSCalibur (BD Biosciences). The cell staining and gating schemes were indicated in the figures, figure legends and results. The specific B cell populations were sorted with BD FACSAria (BD Biosciences). The flow cytometry data were analyzed using BD FACSDiva and FlowJo softwares. For FACS analyses of bone marrow B cell subpopulations, two femurs from each mouse were used for immunofluorescence staining and cell sorting.
Immunoprecipitation (IP)
Dynabeads TM Protein G beads (Invitrogen) were first washed twice with PBS containing 0.5% BSA and 0.05% Triton X-100 then incubated with specific antibodies (about 2 mg antibody for each IP assay) in the same buffer for 2 to 3 h or overnight at 4 C. The conjugated antibodies then were incubated with nuclear extracts (NE) derived from 697 cells or Namalwa cells overnight at 4 C. About 200 mg of NE was used for each IP assay. After washing with buffer BC200 [20 mM Tris (pH 7.9), 0.2 mM EDTA, 1 mM DTT, 0.2 mM PMSF, 20% glycerol, and 200 mM of KCl] for three times, the immunoprecipitates were subject to immunoblot.
RNA isolation and reverse transcription (RT)
Total RNA was isolated from sorted primary B cells or cultured 697 cells using Arcturus TM PicoPure RNA isolation Kit (Applied Biosystems). For each sample, 40 to 100 mg RNA was used for reverse transcription using qScript cDNA SuperMix (Quanta Biosciences) according to Manufacturer's instruction.
Quantitative PCR Quantitative PCR (qPCR) assays were performed in triplicate using QuaniTect SYBR Green PCR mix (QIAGEN) on a 7300 Real Time PCR System (Applied Biosystems). The numbers of biological samples and independent experiments used for qPCR analyses are indicated in the figure legends and text. mRNA levels were normalized to the expression level of Hprt (HPRT) or Gapdh (GAPDH) gene in mouse and human cells. For deletion efficiency and immunoglobulin gene rearrangement analyses, genomic DNA amounts were normalized to promoter regions of Cd79b or Cdk6 genes. Primer sequences for RT-qPCR and qPCR are listed in Table S6 .
RNA-seq and gene ontology mRNA Prepration Kit (Illumina). The sequencing was done by the Genomics Core Facility at The Rockefeller University using an Illumina HiSeq 2500 Sequencer. Sequencing data were aligned to mm10 reference genome on Galaxy (https://usegalaxy.org/) with default parameters using TopHat software (Kim et al., 2013) . The aligned sequences were assembled using Cufflinks and then analyzed using edgeR package in R script (Robinson et al., 2010; Trapnell et al., 2010) . The cut-off line for differential gene expression levels was 1.5 fold with p values smaller than 0.05. Enrichr (http://amp.pharm.mssm.edu/Enrichr/) was used for gene ontology analysis and GSEA was used for gene set enrichment analysis (Kuleshov et al., 2016; Subramanian et al., 2005) . Figure 2E and described in Table S6 . The V K J K recombination efficiencies in pre-B cells were measured by qPCR using primers indicated in Figure 2G and described in Table S6 . A universal V k primer was used in combination with a J k 1, J k 2, J k 4 or J k 5 primer. Promoter regions of Cd79b or Cdk6 genes were used to normalize genomic DNA amounts of different samples. The number of samples used in the assays can be found in the corresponding Figure Legends .
Chromatin immunoprecipitation (ChIP) and ChIP-sequencing The antibodies used for ChIP are described in Key Resources Table. Normal rabbit IgG (sc-2027, Santa Cruz Biotechnology Inc.) was used as an immunoprecipitation control. In ChIP experiments, cells were incubated sequentially, at room temperature (RT), for 30 min in 2mM disuccinimidyl glutarate (DSG), for 10 min after formaldehyde addition to a final concentration of 1%, and for 5 min after addition of glycine to a final concentration of 125mM. Fixed cells were washed twice with cold PBS and resuspended in RIPA 0.3 buffer (0.1% SDS, 1% Triton X-100, 10mM Tris-HCl(pH7.4), 1mM EDTA (pH8.0), 0.1% Sodium Deoxycholate, and 0.3M NaCl). The antibodies and IgG were first incubated with Dynabeads Protein G (Invitrogen) at 4 C overnight, then washed and then incubated with sonicated cell lysate (1-2ug antibody for a ChIP-qPCR, 6-10ug antibody for ChIP-seq) at 4 overnight. For reverse crosslinking, the beads were first washed 4-8 times with high salt buffer (20mM Tris pH8, 2mM EDTA, 0.1%SDS, 1%TX100, 500mM NaCl), then washed with TE buffer (pH8.0) and then washed with elution buffer (1% SDS in TE buffer) for 15 min at RT. Eluates were then incubated at 65
C for 4 h after addition of NaCl and RNase to final concentrations of 200mM and 4ug/ml and then at 55 C for 1 h after addition of proteinase K to100ug/ml. Finally, the immunoprecipitated DNA samples were purified by QIAquick PCR Purification Kit (QIAGEN) for further analysis. About 2-5 ng of DNA precipitated by ChIP was used as the starting material for the generation of singleend sequencing libraries as described (Yu et al., 2015) . Cluster generation and sequencing was performed by the Genomics Resource Center at The Rockefeller University with a HiSeq 2500 system with a read length of 50 nucleotides according to the manufacturer's guidelines (Illumina).
Data analysis for ChIP-seq
The softwares used for ChIP-seq data analyses are listed in Key Resources Table. In brief, sequencing data were aligned using Bowtie2 (Langmead and Salzberg, 2012) to hg19 version of the reference genome on Galaxy (https://usegalaxy.org/) with default parameters. Duplicate mapped reads were removed using Samtools with the rmdup option. Bedgraph files were generated by Homer using makeUCSCfile program with default parameters (Li et al., 2009) . ChIP-seq tracks generated by converting bedgraph files to tdf formats were displayed by IGV software (Robinson et al., 2011) . Peak files were generated by Homer using findPeaks program with default parameters (Heinz et al., 2010) . The threshold for statistical significance of peaks was set at 10 À10 . Annotation of filtered peaks was done by Homer with annotatePeaks program with default parameters except -style factor. ChIP-seq signals at TSSs were plotted as averaged profiles or heatmaps by ngsplot with parameter -SC global -GO max. ChIP-seq signals at enhancers were plotted as averaged profiles by ngsplot with parameter -L 10000 -F Gm12878 -SC global -GO max (Shen et al., 2014) . Motif analyses were performed by Homer using findMotifsGenome program with default parameters.
shRNA knockdown For knockdown of the OCA-B gene, 1x10 7 697 cells were infected with lentivirus carrying OCA-B shRNA sequences or scramble RNA sequence plus 8 mg/ml polybrene in RPMI 1640 medium with 10% FBS. After 12 h, the infected cells were changed to fresh medium with 10% FBS and cultured for 2 days. The cells were then treated with 1 mg/ml puromycin and cultured for another 2 days. Total RNAs were isolated for measuring expression levels of OCA-B by RT-qPCR.
Immunization and immunoglobulin (Ig) class switch Sheep red blood cells (SRBC) were washed with PBS and 1:10 diluted in PBS. 500 mL diluted SRBC were intraperitoneal injected to each mouse. Splenic cells were isolated on day 9 or day 10 after immunization for FACS analysis of germinal center B cells. For Ig class switch assay, naive splenic B cells were enriched by negative selection using anti-CD43 conjugated magnetic beads (Miltenyi Biotec). Isolated cells, at a concentration of 300 to 500K cell per ml, were incubated in RPMI 1640 medium with 10% FCS. Ig class switching were induced by 5ng/ml IL-4 (Sigma) + 25ug/ml LPS (Sigma) (for IgG1), 25ug/ml LPS (for IgG3), and 5ng/ml IL-4 + 0.2mg/ml anti-CD40 antibody (BioLegend) + 0.1ng/ml TGF-b (BioLegend) (for IgA) respectively. After incubation for three days, the cells were analyzed by flow cytometry for specific Ig surface markers.
QUANTIFICATION AND STATISTICAL ANALYSIS
All data were analyzed using Excel or GraphPad Prism softwares. t tests were used for calculation of statistical significance when comparing data from two groups. Differences were considered significant when p values were < 0.05. p values are depicted in figures using one to three asterisks (*p < 0.05, **p < 0.01, and ***p < 0.005). Data are presented as mean + SD with n indicating the number of animals or independent experiments if not stated otherwise in the figure legends or in the text.
DATA AND CODE AVAILABILITY
The RNA-seq and ChIP-seq data have been deposited in NCBI Gene Expression Omnibus. The accession number for the RNA-seq data reported in this paper is GSE107885, and the accession number for the ChIP-seq data reported in this paper is GSE107886. Figure 1, 2, 3, 6 , S1, S3, S5, and S6.
ChIP primers for human genes hIgll1-ChIP-F1 5'-CAC AGC AGG GCA GTT GGC AGA TG-3' hIgll1-ChIP-R1 5'-CGC TGG CAG CAG CTG TCC CAT TG-3' hVpreB1-ChIP-F1 5'-TCCTCCCTGAATGCTTCCATA-3' hVpreB1-ChIP-R1 5'-GGCCACTACCATCCCAGACTT-3' hCNAP1-ChIP-F1 5'-ATG GTT GCC ACT GGG GAT CT-3' hCNAP1-ChIP-R1 5'-TGC CAA AGC CTA GGG GAA GA-3' ChIP primers for mouse genes mIgll1-ChIP-F1
5'-CTGTGAGTGAAAACAGTTAGGCTTGC -3' mIgll1-ChIP-R1 5'-ACCAGCAGGCACACCCCAGTG-3' mVpreB1-ChIP-F1 5'-CATCAGCCACCATTAGCATC-3' mVpreB1-ChIP-R1 5'-ACCCTGGTGCTTGTCTGAGT -3' mCd79b-ChIP-F1 5'-GCAAGCAGAAATGTGACAGC-3' mCd79b-ChIP-R1 5'-GATGATGAGGAGGGTCTGGA-3' mCdk6-ChIP-F1 5'-GCCCAAGTTCAGTTCTCAGC-3' mCdk6-ChIP-F2
5'-CGTCTCTGTGTGTGGGAATG-3' Primers for human gene expression hIgll1-RT-F 5'-ACCCAGCTCACCGTTTTAAGT-3' hIgll1-RT-R 5'-GGTCACCGTCAAGATTCCCG-3' hVpreB1-RT-F1
5'-CGACCATGACATCGGTGTGTA-3' hVpreB1-RT-R1
5'-GGCTCTTGTCTGATTGTGAGAA-3' hHPRT-RT-F1
5'-CCTGGCGTCGTGATTAGTGAT-3' hHPRT-RT-R1
5'-AGACGTTCAGTCCTGTCCATAA-3' hGAPDH-RT-F 5'-TGTGGGCATCAATGGATTTGG-3' hGAPDH-RT-R 5'-ACACCATGTATTCCGGGTCAAT-3' Primers for mouse gene expression mIgll1-RT-F 5'-GAGACAACCCAACCCTCCAA-3' mIgll1-RT-R 5'-TGAGGCATCCACTGGTCAGA-3' mVpreB1-RT-F1 5'-GCTGCTGGCCTATCTCACAG-3' mVpreB1-RT-R1 5'-CCAATGTTATGGTCGTTGCTCA-3' mMta2-RT-F1 5'-GCAATCCTTACCTGGTTAGACG-3' mMta2-RT-R1
5'-TGGCTGGTAATGATTCAAACTG-3' mHprt-RT-F 5'-AGTCCCAGCGTCGTGATTAG-3' mHprt-RT-R 5'-TTTCCAAATCCTCGGCATAATGA-3' mGapdh-RT-F 5'-TGTGTCCGTCGTGGATCTGA-3' mGapdh-RT-R 5'-CCTGCTTCACCACCTTCTTGA-3' mAdcy6-RT-F1
5'-TGAGTCTTCTAGCCAGCTCTG-3' mAdcy6-RT-R1
5'-CAGCACCAAGTAGGTGAACCC-3' mCcnd2-RT-F1
5'-GAGTGGGAACTGGTAGTGTTG-3' mCcnd2-RT-R1
5'-CGCACAGAGCGATGAAGGT-3' mCox6a2-RT-F1
5'-CTGCTCCCTTAACTGCTGGAT-3' mCox6a2-RT-R1
5'-GATTGTGGAAAAGCGTGTGGT-3' mErf-RT-F 5'-GGTTTGCCTTCCCAGATTGG-3' mErf-RT-R 5'-CCTGGTACTCCTCTTTCCGAA-3' mH1f0-RT-F 5'-CACGGACCACCCCAAGTATTC-3'
